| Year |
Citation |
Score |
| 2020 |
Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA, Öz G, Rooney WD, Smith SA, Calabresi PA, Henry RG, et al. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 30: 251-266. PMID 32418324 DOI: 10.1111/Jon.12700 |
0.307 |
|
| 2020 |
Öz G, Deelchand DK, Wijnen JP, Mlynárik V, Xin L, Mekle R, Noeske R, Scheenen TWJ, Tkáč I. Advanced single voxel H magnetic resonance spectroscopy techniques in humans: Experts' consensus recommendations. Nmr in Biomedicine. e4236. PMID 31922301 DOI: 10.1002/Nbm.4236 |
0.327 |
|
| 2019 |
Deelchand DK, Joers JM, Ravishankar A, Lyu T, Emir UE, Hutter D, Gomez CM, Bushara KO, Lenglet C, Eberly LE, Öz G. Sensitivity of Volumetric Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy to Progression of Spinocerebellar Ataxia Type 1. Movement Disorders Clinical Practice. 6: 549-558. PMID 31538089 DOI: 10.1002/Mdc3.12804 |
0.313 |
|
| 2019 |
Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, Brindle KM, Choi IY, Cudalbu C, Dydak U, Emir UE, Gonzalez RG, Gruber S, Gruetter R, Gupta RK, et al. Methodological consensus on clinical proton MRS of the brain: Review and recommendations. Magnetic Resonance in Medicine. PMID 30919510 DOI: 10.1002/Mrm.27742 |
0.331 |
|
| 2019 |
Kartha RV, Joers J, Terluk M, Tuite P, Mishra U, Rudser K, Oz G, Weinreb NJ, Jarnes-Utz J, Cloyd JC. Preliminary N-acetylcysteine results for LDN 6722 - Role of oxidative stress and inflammation in Gaucher disease type 1: Potential use of antioxidant anti-inflammatory medications Molecular Genetics and Metabolism. 126. DOI: 10.1016/J.Ymgme.2018.12.201 |
0.32 |
|
| 2018 |
Cheong I, Deelchand DK, Eberly LE, Marjańska M, Manousakis G, Guliani G, Walk D, Öz G. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30467209 DOI: 10.1136/Jnnp-2018-318795 |
0.31 |
|
| 2018 |
Joers JM, Deelchand DK, Lyu T, Emir UE, Hutter D, Gomez CM, Bushara KO, Eberly LE, Öz G. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias. Annals of Neurology. PMID 29575033 DOI: 10.1002/Ana.25212 |
0.315 |
|
| 2017 |
Coles LD, Tuite PJ, Öz G, Mishra UR, Kartha RV, Sullivan KM, Cloyd JC, Terpstra M. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress. Journal of Clinical Pharmacology. PMID 28940353 DOI: 10.1002/Jcph.1008 |
0.312 |
|
| 2017 |
Cheong I, Marjańska M, Deelchand DK, Eberly LE, Walk D, Öz G. Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis. Neurochemical Research. PMID 28367604 DOI: 10.1007/S11064-017-2248-2 |
0.309 |
|
| 2016 |
Öz G, DiNuzzo M, Kumar A, Moheet A, Khowaja A, Kubisiak K, Eberly LE, Seaquist ER. Cerebral glycogen in humans following acute and recurrent hypoglycemia: Implications on a role in hypoglycemia unawareness. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27834283 DOI: 10.1177/0271678X16678240 |
0.337 |
|
| 2016 |
Joers JM, Deelchand DK, Kumar A, Moheet A, Seaquist E, Henry PG, Öz G. Measurement of Hypothalamic Glucose Under Euglycemia and Hyperglycemia by MRI at 3T. Journal of Magnetic Resonance Imaging : Jmri. PMID 27402249 DOI: 10.1002/Jmri.25383 |
0.319 |
|
| 2015 |
Öz G, DiNuzzo M, Kumar A, Moheet A, Seaquist ER. Revisiting Glycogen Content in the Human Brain. Neurochemical Research. PMID 26202425 DOI: 10.1007/S11064-015-1664-4 |
0.333 |
|
| 2015 |
Öz G. MR Spectroscopy: A Longitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease? Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1304-5. PMID 26184363 DOI: 10.1002/Mds.26322 |
0.302 |
|
| 2015 |
Adanyeguh IM, Henry PG, Nguyen TM, Rinaldi D, Jauffret C, Valabregue R, Emir UE, Deelchand DK, Brice A, Eberly LE, Öz G, Durr A, Mochel F. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 662-70. PMID 25773989 DOI: 10.1002/Mds.26181 |
0.331 |
|
| 2015 |
van de Bank BL, Emir UE, Boer VO, van Asten JJ, Maas MC, Wijnen JP, Kan HE, Oz G, Klomp DW, Scheenen TW. Multi-center reproducibility of neurochemical profiles in the human brain at 7 T. Nmr in Biomedicine. 28: 306-16. PMID 25581510 DOI: 10.1002/Nbm.3252 |
0.334 |
|
| 2015 |
Öz G, Kittelson E, Demirgöz D, Rainwater O, Eberly LE, Orr HT, Clark HB. Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology. Neurobiology of Disease. 74: 158-66. PMID 25446943 DOI: 10.1016/J.Nbd.2014.11.011 |
0.306 |
|
| 2015 |
Deelchand DK, Adanyeguh IM, Emir UE, Nguyen TM, Valabregue R, Henry PG, Mochel F, Öz G. Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single-voxel MRS at 3T. Magnetic Resonance in Medicine. 73: 1718-25. PMID 24948590 DOI: 10.1002/Mrm.25295 |
0.341 |
|
| 2015 |
Khowaja A, Choi IY, Seaquist ER, Öz G. In vivo Magnetic Resonance Spectroscopy of cerebral glycogen metabolism in animals and humans. Metabolic Brain Disease. 30: 255-61. PMID 24676563 DOI: 10.1007/S11011-014-9530-7 |
0.354 |
|
| 2014 |
Oz G, Alger JR, Barker PB, Bartha R, Bizzi A, Boesch C, Bolan PJ, Brindle KM, Cudalbu C, Dinçer A, Dydak U, Emir UE, Frahm J, González RG, Gruber S, et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology. 270: 658-79. PMID 24568703 DOI: 10.1148/Radiol.13130531 |
0.347 |
|
| 2013 |
Cui W, Zhu XH, Vollmers ML, Colonna ET, Adriany G, Tramm B, Dubinsky JM, Öz G. Non-invasive measurement of cerebral oxygen metabolism in the mouse brain by ultra-high field (17)O MR spectroscopy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1846-9. PMID 24064490 DOI: 10.1038/Jcbfm.2013.172 |
0.317 |
|
| 2012 |
Emir UE, Auerbach EJ, Van De Moortele PF, Marjańska M, Uğurbil K, Terpstra M, Tkáč I, Oz G. Regional neurochemical profiles in the human brain measured by ¹H MRS at 7 T using local B₁ shimming. Nmr in Biomedicine. 25: 152-60. PMID 21766380 DOI: 10.1002/Nbm.1727 |
0.364 |
|
| 2011 |
Oz G, Vollmers ML, Nelson CD, Shanley R, Eberly LE, Orr HT, Clark HB. In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Experimental Neurology. 232: 290-8. PMID 21963649 DOI: 10.1016/J.Expneurol.2011.09.021 |
0.329 |
|
| 2011 |
Tesfaye N, Seaquist ER, Oz G. Noninvasive measurement of brain glycogen by nuclear magnetic resonance spectroscopy and its application to the study of brain metabolism. Journal of Neuroscience Research. 89: 1905-12. PMID 21732401 DOI: 10.1002/Jnr.22703 |
0.357 |
|
| 2011 |
Oz G, Tkáč I. Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem. Magnetic Resonance in Medicine. 65: 901-10. PMID 21413056 DOI: 10.1002/Mrm.22708 |
0.311 |
|
| 2011 |
Oz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum (London, England). 10: 208-17. PMID 20838948 DOI: 10.1007/S12311-010-0213-6 |
0.35 |
|
| 2010 |
Iltis I, Hutter D, Bushara KO, Clark HB, Gross M, Eberly LE, Gomez CM, Oz G. (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Research. 1358: 200-10. PMID 20713024 DOI: 10.1016/J.Brainres.2010.08.030 |
0.361 |
|
| 2010 |
Oz G, Hutter D, Tkác I, Clark HB, Gross MD, Jiang H, Eberly LE, Bushara KO, Gomez CM. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1253-61. PMID 20310029 DOI: 10.1002/Mds.23067 |
0.348 |
|
| 2010 |
Oz G, Nelson CD, Koski DM, Henry PG, Marjanska M, Deelchand DK, Shanley R, Eberly LE, Orr HT, Clark HB. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 3831-8. PMID 20220018 DOI: 10.1523/Jneurosci.5612-09.2010 |
0.322 |
|
| 2007 |
Michaeli S, Oz G, Sorce DJ, Garwood M, Ugurbil K, Majestic S, Tuite P. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 334-40. PMID 17149719 DOI: 10.1002/Mds.21227 |
0.305 |
|
| 2006 |
Henry PG, Adriany G, Deelchand D, Gruetter R, Marjanska M, Oz G, Seaquist ER, Shestov A, Uğurbil K. In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective. Magnetic Resonance Imaging. 24: 527-39. PMID 16677959 DOI: 10.1016/J.Mri.2006.01.003 |
0.307 |
|
| 2005 |
Öz G, Henry PG, Tkáĉ I, Gruetter R. A localization method for the measurement of fast relaxing13C NMR signals in humans at high magnetic fields Applied Magnetic Resonance. 29: 159-169. DOI: 10.1007/Bf03166961 |
0.327 |
|
| 2004 |
Oz G, Berkich DA, Henry PG, Xu Y, LaNoue K, Hutson SM, Gruetter R. Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11273-9. PMID 15601933 DOI: 10.1523/Jneurosci.3564-04.2004 |
0.316 |
|
| 2003 |
Henry PG, Oz G, Provencher S, Gruetter R. Toward dynamic isotopomer analysis in the rat brain in vivo: automatic quantitation of 13C NMR spectra using LCModel. Nmr in Biomedicine. 16: 400-12. PMID 14679502 DOI: 10.1002/Nbm.840 |
0.338 |
|
| 2003 |
Gruetter R, Adriany G, Choi IY, Henry PG, Lei H, Oz G. Localized in vivo 13C NMR spectroscopy of the brain. Nmr in Biomedicine. 16: 313-38. PMID 14679498 DOI: 10.1002/Nbm.841 |
0.347 |
|
| 2003 |
Oz G, Henry PG, Seaquist ER, Gruetter R. Direct, noninvasive measurement of brain glycogen metabolism in humans. Neurochemistry International. 43: 323-9. PMID 12742076 DOI: 10.1016/S0197-0186(03)00019-6 |
0.342 |
|
| 2001 |
Zangger K, Shen G, Oz G, Otvos JD, Armitage IM. Oxidative dimerization in metallothionein is a result of intermolecular disulphide bonds between cysteines in the alpha-domain. The Biochemical Journal. 359: 353-60. PMID 11583581 DOI: 10.1042/0264-6021:3590353 |
0.555 |
|
| 2001 |
Oz G, Zangger K, Armitage IM. Three-dimensional structure and dynamics of a brain specific growth inhibitory factor: metallothionein-3. Biochemistry. 40: 11433-41. PMID 11560491 DOI: 10.1021/Bi010827L |
0.553 |
|
| 2001 |
Zangger K, Oz G, Haslinger E, Kunert O, Armitage IM. Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1303-5. PMID 11344121 DOI: 10.1096/Fj.00-0641Fje |
0.557 |
|
| 2000 |
Zangger K, Oz G, Armitage IM. Re-evaluation of the binding of ATP to metallothionein. The Journal of Biological Chemistry. 275: 7534-8. PMID 10713058 DOI: 10.1074/Jbc.275.11.7534 |
0.519 |
|
| 2000 |
Zangger K, Oz G, Otvos J, Armitage I. 1H Chemical Shift Assignements for mouse [Cd7]-metallothionein-1 Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr4462 |
0.521 |
|
| 1999 |
Zangger K, Oz G, Otvos JD, Armitage IM. Three-dimensional solution structure of mouse [Cd7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy. Protein Science : a Publication of the Protein Society. 8: 2630-8. PMID 10631978 DOI: 10.1110/Ps.8.12.2630 |
0.56 |
|
| 1998 |
Oz G, Pountney DL, Armitage IM. NMR spectroscopic studies of I = 1/2 metal ions in biological systems. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 76: 223-34. PMID 9923691 DOI: 10.1139/Bcb-76-2-3-223 |
0.537 |
|
| Show low-probability matches. |